We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGM icon
5826
iShares Expanded Tech Sector ETF
IGM
$10.8B
-9
Closed -$863
IGOV icon
5827
iShares International Treasury Bond ETF
IGOV
$1.54B
-71
Closed -$2.97K
IGR
5828
CBRE Global Real Estate Income Fund
IGR
$713M
-686
Closed -$4.51K
IHE icon
5829
iShares US Pharmaceuticals ETF
IHE
$1.64B
-4,012
Closed -$283K
IJH icon
5830
iShares Core S&P Mid-Cap ETF
IJH
$127B
-34,256
Closed -$2.13M
IJK icon
5831
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
-12,508
Closed -$1.15M
IKT icon
5832
Inhibikase Therapeutics
IKT
$388M
-4,057
Closed -$5.27K
ILCG icon
5833
iShares Morningstar Growth ETF
ILCG
$3.28B
-69
Closed -$5.8K
NBP
5834
NovaBridge Biosciences American Depositary Shares
NBP
$202M
-4,015
Closed -$4.98K
IMCV icon
5835
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
-1,476
Closed -$113K
INCO icon
5836
Columbia India Consumer ETF
INCO
$239M
-7
Closed -$539
INDY icon
5837
iShares S&P India Nifty 50 Index Fund
INDY
$569M
-183
Closed -$10.3K
INHD icon
5838
Inno Holdings
INHD
$23.2M
0
-$88
INTZ
5839
Intrusion
INTZ
$17.3M
-2,562
Closed -$2.2K
IPWR icon
5840
Ideal Power
IPWR
$74.2M
-494
Closed -$4.05K
IROQ
5841
DELISTED
IF Bancorp
IROQ
-26
Closed -$524
ISCV icon
5842
iShares Morningstar Small-Cap Value ETF
ISCV
$706M
-7,638
Closed -$485K
ISD
5843
PGIM High Yield Bond Fund
ISD
$419M
-672
Closed -$9.37K
IVOO icon
5844
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.92B
-550
Closed -$58.1K
IVW icon
5845
iShares S&P 500 Growth ETF
IVW
$77.6B
-17
Closed -$1.63K
IWB icon
5846
iShares Russell 1000 ETF
IWB
$50.2B
-97,081
Closed -$30.5M
IX icon
5847
ORIX
IX
$43.5B
-80
Closed -$1.86K
IYG icon
5848
iShares US Financial Services ETF
IYG
$2.2B
-6,151
Closed -$437K
IYW icon
5849
iShares US Technology ETF
IYW
$25.5B
-45,025
Closed -$6.83M
JAGX icon
5850
Jaguar Health
JAGX
$4.67M
-3
Closed -$3.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.